Is a Change of Factor VIII Product a Risk Factor for the Development of a Factor VIII Inhibitor?

Please copy the URL and add it into your RSS Feed Reader.

Thromb Haemost 1999; 81(05): 852
DOI: 10.1055/s-0037-1614585

Letters to the Editor

Schattauer GmbH

Authors

Thynn Thynn Yee

¹From the Katharine Dormandy Haemophilia Centre and Haemostasis Unit, Department of Haematology, Royal Free and University College Medical School, University College London, U.K.
C. A. Lee

¹From the Katharine Dormandy Haemophilia Centre and Haemostasis Unit, Department of Haematology, Royal Free and University College Medical School, University College London, U.K.

Received 31 December 1998

Accepted 08 February 1999

Publication Date:
09 December 2017 (online)

References
1 Baglin T, Beacham E.. Is a change of factor VIII product a risk factor for the development of a factor VIII inhibitor? Thromb Haemost. 1998; 80:: 1036-7.

Reference Link Ris
PubMed Search in Google Scholar
2 Yee TT, Lee CA, Riddel A, Pasi KJ. From Tolerance to Intolerance of factor VIII: A Clinical Case Presentation. C.M.E.. Bulletin 1997; 1: 16-7.

Reference Link Ris
PubMed Search in Google Scholar
3 Antonarakis SE, Kazazian HH, Gitschier J, Hutter P, de Moerloose P, Morris MA. Molecular etiology of factor VIII deficiency in haemophilia A. Advances in experimental medicine and biology.. Ed by Aledort L. M., Hoyer L. W., Lusher J. M., Reisner H. M., and C. G.. White II. 1996; 386: 19-34.

Reference Link Ris
PubMed Search in Google Scholar
4 Lee CA. Investigation of chronic hepatitis C infection in individuals with haemophilia.. Br J Haematol 1997; 96: 425

Reference Link Ris
Crossref PubMed Search in Google Scholar